For research use only. PeptaBase is for informational and laboratory research reference only. No medical claims are made and nothing on this site is intended to diagnose, treat, cure or prevent any disease.
PeptaBase
500+ PubMed CitationsFree To UseNo Account Required
Back to Database
Bioregulators

Cerebrolysin Protocol

Dosing & Research

Last Updated: September 4, 2026

Stroke and TBI recovery research, Cognitive impairment models, Neurotrophic signaling, Neuroplasticity studies

Half-Life
Complex mixture; single half-life not well defined
Administration
Intramuscular
Frequency
Once Daily (acute) Or 5 Days Weekly (chronic)

How It Works

  • Stroke and TBI recovery research
  • Cognitive impairment models
  • Neurotrophic signaling
  • Neuroplasticity studies

Dosing Structure

Dose
10–50 mL
Frequency
Once Daily (acute) Or 5 Days Weekly (chronic)
Notes
IM: up to 5mL per injection. Morning preferred. Break: 1-3 months for chronic conditions. Typically administered as defined courses (10–20 days) repeated 1–2x per year, rather than continuous daily dosing. Based on Khavinson Institute and associated Russian clinical research.

Example Protocols

Dose: 10–50 mL
Frequency: Once Daily (acute) Or 5 Days Weekly (chronic)
Duration: Acute: 7-30 days; Chronic: 4 weeks (2-4 cycles yearly)
Off Period: Not listed
Calculate dosing →

Find Research Grade Cerebrolysin

Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.

Vendor One Research Labs

COA Verified

Third-party COA-verified research peptides with published batch testing.

Source Coming Soon

Vendor Two Sciences

Purity Tested

US-based research compound supplier with independent purity testing.

Source Coming Soon

Vendor Three Peptide Co.

Bulk research peptide sourcing with batch-level documentation.

Source Coming Soon
View all recommended vendors →

Protocol Notes

IM: up to 5mL per injection.
Morning preferred.
Break: 1-3 months for chronic conditions.
Typically administered as defined courses (10–20 days) repeated 1–2x per year, rather than continuous daily dosing.
Based on Khavinson Institute and associated Russian clinical research.

Research & Studies

Loading citations…

    Research Feedback

    0 approved

    For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.

    Related Peptides

    Bonomarlot
    Bioregulators
    Bonothyrk
    Bioregulators
    Bronchogen
    Bioregulators
    Cardiogen
    Bioregulators